| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699859 | Clinical Oncology | 2012 | 8 Pages |
Abstract
A single, initial IMRT plan with appropriate margins encompassing initial gross and potential microscopic pelvic disease leads to a reduction in the dose to OAR without compromising target coverage. This offers a potential 'class solution' for definitive treatment of patients with cervical cancer. Clinical outcome data are still needed to verify this planning study.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
J. Forrest, J. Presutti, M. Davidson, P. Hamilton, A. Kiss, G. Thomas,